Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

Liu, Xinxue; Munro, Alasdair PS; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; +49 more... Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N; COV-BOOST study group; (2022) Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial. The Journal of infection, 84 (6). pp. 795-813. ISSN 0163-4453 DOI: https://doi.org/10.1016/j.jinf.2022.04.018

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.jinf.2022.04.018

Abstract

Share

Download

Filename: Liu_etal_2022_Persistence-of-immunogenicity-after-seven.pdf

Licence: Creative Commons: Attribution 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar